Updates in the Front-Line Management of Metastatic/Unresectable Endometrial Cancer: Mt. Sinai Hospital ONLY
At the Hospital or Via Zoom
At the completion of this activity, the participant will be able to:
Describe the epidemiology, pathophysiology, and diagnostics of endometrial cancer
Identify molecular targets and evaluate literature supporting targeted/immunotherapies in endometrial cancer
Review literature that supports the use of targeted therapies/immunotherapies in the upfront management of endometrial cancer
List drug-specific considerations which may impact patient care
o Bianca Bucuresteanu/PGY2 Oncology Pharmacy Resident/PharmD, MHS
o Dr. Bianca Bucuresteanu is from Springfield, NJ. She received her Doctor of Pharmacy degree at Fairleigh Dickinson University in 2022. She completed her PGY-1 pharmacy residency at Penn Medicine Princeton Medical Center in Plainsboro, NJ. Her professional interests include hematologic malignancies and clinical trial research. Her future goals include practicing at an academic institution and precepting.
ACPE UAN # 0042-0000-23-093-L01-P
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.